tiprankstipranks
JD Health International, Inc. (HK:6618)
:6618
Hong Kong Market
6618
JD Health International, Inc.
RESEARCH TOOLSreports
Want to see HK:6618 full AI Analyst Report?

JD Health International, Inc. (6618) Stock Forecast & Price Target

23 Followers
See the Price Targets and Ratings of:

6618 Analyst Ratings

Strong Buy
14Ratings
Strong Buy
13 Buy
1 Hold
0 Sell
Based on 14 analysts giving stock ratings to
JD
Health International, Inc.
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

6618 Stock 12 Month Forecast

Average Price Target

HK$71.75
▲(18.99% Upside)
Based on 14 Wall Street analysts offering 12 month price targets for JD Health International, Inc. in the last 3 months. The average price target is HK$71.75 with a high forecast of HK$92.79 and a low forecast of HK$58.28. The average price target represents a 18.99% change from the last price of HK$60.30.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"38":"HK$38","93":"HK$93","51.75":"HK$51.8","65.5":"HK$65.5","79.25":"HK$79.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":92.79,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">HK$92.79</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":71.74928571428572,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">HK$71.75</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":58.28,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">HK$58.28</span>\n  </div></div>","useHTML":true}}],"tickPositions":[38,51.75,65.5,79.25,93],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2025","6":"Dec<br/>2025","9":"Mar<br/>2026","12":"Jun<br/>2026","25":"Jun<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,39.12,43.248461538461534,47.37692307692308,51.505384615384614,55.63384615384615,59.762307692307694,63.89076923076923,68.01923076923077,72.14769230769231,76.27615384615385,80.4046153846154,84.53307692307692,88.66153846153847,{"y":92.79,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,39.12,41.629945054945054,44.13989010989011,46.64983516483517,49.15978021978022,51.66972527472528,54.17967032967033,56.68961538461539,59.19956043956044,61.7095054945055,64.21945054945056,66.7293956043956,69.23934065934067,{"y":71.74928571428572,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,39.12,40.59384615384615,42.067692307692305,43.54153846153846,45.01538461538461,46.489230769230765,47.963076923076926,49.43692307692308,50.91076923076923,52.38461538461539,53.85846153846154,55.332307692307694,56.80615384615385,{"y":58.28,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":39.8,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":43,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":48.75,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":64.1,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":66.5,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":60.7,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":63.5,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":55.5,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":60.95,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":53.8,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":48.64,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":45.36,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":39.12,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price TargetHK$92.79Average Price TargetHK$71.75Lowest Price TargetHK$58.28
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Citic Securities Analyst forecast on HK:6618
Unknown Analyst
Citic Securities
Not Ranked
Citic Securities
HK$74
Buy
22.72%
Upside
Reiterated
06/03/26
Citic Securities Reaffirms Their Buy Rating on JD Health International, Inc. (6618)
Bank of America Securities Analyst forecast on HK:6618
Unknown Analyst
Bank of America Securities
Not Ranked
Bank of America Securities
HK$75→HK$68
Buy
12.77%
Upside
Reiterated
05/21/26
JD Health International, Inc. (6618) Gets a Buy from Bank of America Securities
CICC Analyst forecast on HK:6618
Unknown Analyst
CICC
Not Ranked
CICC
HK$66.2
Buy
9.78%
Upside
Reiterated
05/16/26
JD Health International, Inc. (6618) Receives a Buy from CICC
CSC Financial Analyst forecast on HK:6618
Unknown Analyst
CSC Financial
Not Ranked
CSC Financial
HK$69.22→HK$58.28
Buy
-3.35%
Downside
Reiterated
05/14/26
CSC Financial Keeps Their Buy Rating on JD Health International, Inc. (6618)
Goldman Sachs Analyst forecast on HK:6618
Unknown Analyst
Goldman Sachs
Not Ranked
Goldman Sachs
HK$66→HK$65
Buy
7.79%
Upside
Reiterated
05/14/26
Goldman Sachs Remains a Buy on JD Health International, Inc. (6618)
Nomura Analyst forecast on HK:6618
Unknown Analyst
Nomura
Not Ranked
Nomura
HK$80→HK$67
Buy
11.11%
Upside
Reiterated
05/14/26
JD Health International, Inc. (6618) Receives a Buy from Nomura
Huatai Securities Analyst forecast on HK:6618
Unknown Analyst
Huatai Securities
Not Ranked
Huatai Securities
HK$65.5→HK$67.4
Buy
11.77%
Upside
Reiterated
05/13/26
JD Health International, Inc. (6618) Receives a Buy from Huatai Securities
UBS Analyst forecast on HK:6618
Unknown Analyst
UBS
Not Ranked
UBS
HK$70.7
Buy
17.25%
Upside
Reiterated
05/13/26
UBS Sticks to Its Buy Rating for JD Health International, Inc. (6618)
HSBC Analyst forecast on HK:6618
Unknown Analyst
HSBC
Not Ranked
HSBC
HK$80→HK$79.5
Buy
31.84%
Upside
Reiterated
05/13/26
HSBC Keeps Their Buy Rating on JD Health International, Inc. (6618)
CLSA Analyst forecast on HK:6618
Unknown Analyst
CLSA
Not Ranked
CLSA
HK$66.5
Buy
10.28%
Upside
Reiterated
05/13/26
CLSA Remains a Buy on JD Health International, Inc. (6618)
Morgan Stanley Analyst forecast on HK:6618
Unknown Analyst
Morgan Stanley
Not Ranked
Morgan Stanley
HK$66
Hold
9.45%
Upside
Reiterated
05/12/26
Morgan Stanley Remains a Hold on JD Health International, Inc. (6618)
China Renaissance Analyst forecast on HK:6618
Unknown Analyst
China Renaissance
Not Ranked
China Renaissance
HK$92.79
Buy
53.88%
Upside
Reiterated
03/11/26
China Renaissance Sticks to Their Buy Rating for JD Health International, Inc. (6618)
Guotai Haitong Analyst forecast on HK:6618
Unknown Analyst
Guotai Haitong
Not Ranked
Guotai Haitong
HK$71.07
Buy
17.86%
Upside
Reiterated
03/09/26
Guotai Haitong Sticks to Their Buy Rating for JD Health International, Inc. (6618)
GF Securities Analyst forecast on HK:6618
Unknown Analyst
GF Securities
Not Ranked
GF Securities
HK$92.05
Buy
52.65%
Upside
Reiterated
03/09/26
GF Securities Sticks to Their Buy Rating for JD Health International, Inc. (6618)
Macquarie Analyst forecast on HK:6618
Ellie Jiang
Macquarie
Macquarie
HK$62.14→HK$74.57
Buy
23.67%
Upside
Reiterated
10/17/25
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Citic Securities Analyst forecast on HK:6618
Unknown Analyst
Citic Securities
Not Ranked
Citic Securities
HK$74
Buy
22.72%
Upside
Reiterated
06/03/26
Citic Securities Reaffirms Their Buy Rating on JD Health International, Inc. (6618)
Bank of America Securities Analyst forecast on HK:6618
Unknown Analyst
Bank of America Securities
Not Ranked
Bank of America Securities
HK$75→HK$68
Buy
12.77%
Upside
Reiterated
05/21/26
JD Health International, Inc. (6618) Gets a Buy from Bank of America Securities
CICC Analyst forecast on HK:6618
Unknown Analyst
CICC
Not Ranked
CICC
HK$66.2
Buy
9.78%
Upside
Reiterated
05/16/26
JD Health International, Inc. (6618) Receives a Buy from CICC
CSC Financial Analyst forecast on HK:6618
Unknown Analyst
CSC Financial
Not Ranked
CSC Financial
HK$69.22→HK$58.28
Buy
-3.35%
Downside
Reiterated
05/14/26
CSC Financial Keeps Their Buy Rating on JD Health International, Inc. (6618)
Goldman Sachs Analyst forecast on HK:6618
Unknown Analyst
Goldman Sachs
Not Ranked
Goldman Sachs
HK$66→HK$65
Buy
7.79%
Upside
Reiterated
05/14/26
Goldman Sachs Remains a Buy on JD Health International, Inc. (6618)
Nomura Analyst forecast on HK:6618
Unknown Analyst
Nomura
Not Ranked
Nomura
HK$80→HK$67
Buy
11.11%
Upside
Reiterated
05/14/26
JD Health International, Inc. (6618) Receives a Buy from Nomura
Huatai Securities Analyst forecast on HK:6618
Unknown Analyst
Huatai Securities
Not Ranked
Huatai Securities
HK$65.5→HK$67.4
Buy
11.77%
Upside
Reiterated
05/13/26
JD Health International, Inc. (6618) Receives a Buy from Huatai Securities
UBS Analyst forecast on HK:6618
Unknown Analyst
UBS
Not Ranked
UBS
HK$70.7
Buy
17.25%
Upside
Reiterated
05/13/26
UBS Sticks to Its Buy Rating for JD Health International, Inc. (6618)
HSBC Analyst forecast on HK:6618
Unknown Analyst
HSBC
Not Ranked
HSBC
HK$80→HK$79.5
Buy
31.84%
Upside
Reiterated
05/13/26
HSBC Keeps Their Buy Rating on JD Health International, Inc. (6618)
CLSA Analyst forecast on HK:6618
Unknown Analyst
CLSA
Not Ranked
CLSA
HK$66.5
Buy
10.28%
Upside
Reiterated
05/13/26
CLSA Remains a Buy on JD Health International, Inc. (6618)
Morgan Stanley Analyst forecast on HK:6618
Unknown Analyst
Morgan Stanley
Not Ranked
Morgan Stanley
HK$66
Hold
9.45%
Upside
Reiterated
05/12/26
Morgan Stanley Remains a Hold on JD Health International, Inc. (6618)
China Renaissance Analyst forecast on HK:6618
Unknown Analyst
China Renaissance
Not Ranked
China Renaissance
HK$92.79
Buy
53.88%
Upside
Reiterated
03/11/26
China Renaissance Sticks to Their Buy Rating for JD Health International, Inc. (6618)
Guotai Haitong Analyst forecast on HK:6618
Unknown Analyst
Guotai Haitong
Not Ranked
Guotai Haitong
HK$71.07
Buy
17.86%
Upside
Reiterated
03/09/26
Guotai Haitong Sticks to Their Buy Rating for JD Health International, Inc. (6618)
GF Securities Analyst forecast on HK:6618
Unknown Analyst
GF Securities
Not Ranked
GF Securities
HK$92.05
Buy
52.65%
Upside
Reiterated
03/09/26
GF Securities Sticks to Their Buy Rating for JD Health International, Inc. (6618)
Macquarie Analyst forecast on HK:6618
Ellie Jiang
Macquarie
Macquarie
HK$62.14→HK$74.57
Buy
23.67%
Upside
Reiterated
10/17/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering JD Health International, Inc.

3 Months
Lincoln KongGoldman Sachs
Success Rate
4/4 ratings generated profit
100%
Average Return
+32.32%
Copying Lincoln Kong's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +32.32% per trade.
1 Year
Lincoln KongGoldman Sachs
Success Rate
2/4 ratings generated profit
50%
Average Return
+19.43%
Copying Lincoln Kong's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +19.43% per trade.
2 Years
Jialong ShiNomura
Success Rate
3/6 ratings generated profit
50%
Average Return
+6.13%
Copying Jialong Shi's trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +6.13% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

6618 Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
0
5
8
10
6
Buy
3
8
7
14
8
Hold
0
0
0
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
3
13
15
25
15
In the current month, 6618 has received 14 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. 6618 average Analyst price target in the past 3 months is 71.75.
Each month's total comprises the sum of three months' worth of ratings.

6618 Financial Forecast

6618 Earnings Forecast

Next quarter’s earnings estimate for 6618 is HK$1.35 with a range of HK$1.35 to HK$1.35. The previous quarter’s EPS was HK$1.08. 6618 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year 6618 has Performed in-line its overall industry.
Next quarter’s earnings estimate for 6618 is HK$1.35 with a range of HK$1.35 to HK$1.35. The previous quarter’s EPS was HK$1.08. 6618 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year 6618 has Performed in-line its overall industry.

6618 Sales Forecast

Next quarter’s sales forecast for 6618 is HK$47.80B with a range of HK$47.47B to HK$48.12B. The previous quarter’s sales results were HK$41.77B. 6618 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year 6618 has Performed in-line its overall industry.
Next quarter’s sales forecast for 6618 is HK$47.80B with a range of HK$47.47B to HK$48.12B. The previous quarter’s sales results were HK$41.77B. 6618 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year 6618 has Performed in-line its overall industry.

6618 Stock Forecast FAQ

What is HK:6618’s average 12-month price target, according to analysts?
Based on analyst ratings, JD Health International, Inc.’s 12-month average price target is 71.75.
    What is HK:6618’s upside potential, based on the analysts’ average price target?
    JD Health International, Inc. has 18.99% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is JD Health International, Inc. a Buy, Sell or Hold?
          JD Health International, Inc. has a consensus rating of Strong Buy, which is based on 13 buy ratings, 1 hold ratings and 0 sell ratings.
            What is JD Health International, Inc.’s share price target?
            The average share price target for JD Health International, Inc. is 71.75. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is HK$92.79 ,and the lowest forecast is HK$58.28. The average share price target represents 18.99% Increase from the current price of HK$60.3.
              What do analysts say about JD Health International, Inc.?
              JD Health International, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 14 Wall Streets Analysts.
                How can I buy shares of JD Health International, Inc.?
                To buy shares of HK:6618, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.